{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:58:50Z","timestamp":1777741130223,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Overactive bladder (OAB) is a common functional disorder in paediatric populations and is associated with significant psychological burden and impaired quality of life. Although oxybutynin is widely used as first-line pharmacological therapy, a substantial proportion of children exhibit incomplete symptom control or limited tolerability. Emerging evidence suggests that targeting metabolic dysfunction, oxidative stress, and neuromuscular excitability may provide additional therapeutic benefit. This retrospective observational study evaluated the clinical impact of an adjunctive nutraceutical formulation containing myo-inositol, microlipodispersed magnesium, folic acid, and vitamin C (LEVIGON\u2122 PRO, Sanitpharma; Milan, Italy) in children with OAB receiving oxybutynin. Methods: Medical records of children diagnosed with OAB were retrospectively reviewed. After applying inclusion and exclusion criteria, 120 patients aged 5\u201315 years were included and allocated to two groups based on documented treatment: oxybutynin plus LEVIGON\u2122 PRO (Group A, n = 60) or oxybutynin alone (Group B, n = 60). The primary outcome was complete daytime urinary continence at Day 112. Secondary outcomes included weekly incontinence episodes, voiding frequency, bladder wall thickness, uroflowmetry parameters, and Patient Perception of Bladder Condition (PPBC) scores. An exploratory subgroup analysis was performed in 34 children with impaired fasting glucose (ifg), assessing fasting glucose, insulin, and homa-ir. results: by day 112, complete daytime continence was achieved in 61.7% of patients in group a and 48.3% in group b (absolute risk difference 13.4%; nnt \u2248 7.5; p = 0.14). across secondary endpoints, the combination therapy group showed significantly greater longitudinal improvements (group \u00d7 time interaction, p &lt; 0.05), including reductions in weekly incontinence episodes, voiding frequency, post-void residual volume, and ppbc scores, as well as increases in mean voided volume, qmax, and reductions in bladder wall thickness. in the ifg subgroup, greater reductions in fasting glucose, fasting insulin, and homa-ir were observed in group a compared with group b (p &lt; 0.01). Both treatments were well tolerated, with no serious adverse events reported. conclusions: adjunctive nutraceutical therapy combined with oxybutynin was associated with greater improvements in several clinically relevant secondary outcomes in children with OAB, with a favourable tolerability profile. Although the primary endpoint did not reach statistical significance, the overall pattern of findings may suggest a possible additive benefit; however, these findings may be influenced by residual confounding inherent to the retrospective observational design. Therefore, the results should be considered hypothesis generating and require confirmation in prospective randomized controlled trials.<\/jats:p>","DOI":"10.3390\/children13050604","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:34:42Z","timestamp":1777458882000},"page":"604","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Adjunctive Myo-Inositol and Magnesium Therapy on Paediatric Overactive Bladder: A Retrospective Analysis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-2788","authenticated-orcid":false,"given":"Alessandro","family":"Colletti","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Science and Technology, University of Turin, 10125 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Favro","sequence":"additional","affiliation":[{"name":"Division of Urology, Maggiore della Carit\u00e0 Hospital, University of Eastern Piedmont, 28100 Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Sangiorgio","sequence":"additional","affiliation":[{"name":"Unit of Pediatric Surgery, Azienda USL della Valle d\u2019Aosta, Specialist Outpatient Clinic, Via Guido Rey 3, 11100 Aosta, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: Report from the Standardisation Committee of the International Children\u2019s Continence Society","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrurol.2016.152","article-title":"Overactive bladder in children","volume":"13","author":"Franco","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fuentes, M., Magalh\u00e3es, J., and Barroso, U. (2019). Diagnosis and management of bladder dysfunction in neurologically normal children. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00298"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the Standardization Committee of the International Children\u2019s Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00345-024-05310-9","article-title":"Effect of standard urotherapy on quality of life in children with overactive bladder","volume":"42","author":"Dai","year":"2024","journal-title":"World J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Cheng, Z., Chai, Y., and Zhang, Y. (2025). The efficacy of parasacral transcutaneous electrical nerve stimulation for the treatment of overactive bladder in children: A systematic review and meta-analysis. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1450634"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5489\/cuaj.6247","article-title":"A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study","volume":"14","author":"Ramsay","year":"2020","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2016.08.061","article-title":"Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial","volume":"71","author":"Newgreen","year":"2017","journal-title":"Eur Urol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Meijer, E.F.J., Nieuwhof-Leppink, A.J., and van Waalwijk van Doorn, E.S. (2015). Central inhibition of refractory overactive bladder complaints: Results of an inpatient training program. J. Pediatr. Urol., 11.","DOI":"10.1016\/j.jpurol.2014.06.024"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5213\/inj.2244228.114","article-title":"Updates of Overactive Bladder in Pediatrics","volume":"27","author":"Shim","year":"2023","journal-title":"Int. Neurourol. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jpepsy\/jsn008","article-title":"Early childhood risk factors associated with daytime wetting and soiling in school-age children","volume":"33","author":"Joinson","year":"2008","journal-title":"J. Pediatr. Psychol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1542\/peds.100.2.228","article-title":"Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood","volume":"100","year":"1997","journal-title":"Pediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MPG.0000000000002138","article-title":"Bladder symptoms in children with functional constipation: A systematic review","volume":"67","author":"Holtman","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hsu, L.-N., Hu, J.-C., Chen, P.-Y., Lee, W.-C., and Chuang, Y.-C. (2022). Metabolic syndrome and overactive bladder syndrome may share common pathophysiologies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081957"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5213\/inj.2012.16.4.181","article-title":"Association of insulin resistance with overactive bladder in female patients","volume":"16","author":"Uzun","year":"2012","journal-title":"Int. Neurourol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1464-410X.2008.07587.x","article-title":"Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract","volume":"102","author":"Pinggera","year":"2008","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.5489\/cuaj.4337","article-title":"Overactive bladder in children","volume":"11","author":"Ramsay","year":"2017","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/09513590801893232","article-title":"Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with PCOS","volume":"24","author":"Genazzani","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Xu, L., Li, X., Wang, X., and Xu, M. (2023). Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1020327"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2337\/diab.41.1.35","article-title":"Effect of Mg2+ on Na+-Dependent Inositol Transport: Role for Mg2+ in Etiology of Diabetic Complications Available to Purchase","volume":"41","author":"Grafton","year":"1992","journal-title":"Diabetes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc12-1371","article-title":"Myo-inositol supplementation and onset of gestational diabetes mellitus","volume":"36","author":"Scilipoti","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Raghu, P. (2019). Phosphoinositides: Regulators of Nervous System Function in Health and Disease. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00208"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9537632","DOI":"10.1155\/2016\/9537632","article-title":"Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study","volume":"2016","author":"Regidor","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pezza, M., Carlomagno, V., Sammarco, E., Trischitta, A., Ceddia, C., Vitiello, A., Baj, G., Citi, V., and Colletti, A. (2025). Myo-inositol and microlipodispersed magnesium in dermatological diseases. Pharmaceuticals, 18.","DOI":"10.3390\/ph18020251"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ALN.0000000000003309","article-title":"Magnesium and Bladder Discomfort after Transurethral Resection of Bladder Tumor: A Randomized, Double-blind, Placebo-controlled Study","volume":"133","author":"Park","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s41043-025-00846-x","article-title":"The association between magnesium depletion score (MDS) and overactive bladder (OAB) among the U.S. population","volume":"44","author":"Gong","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.neuropharm.2011.12.029","article-title":"Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations","volume":"62","author":"Nikolaev","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Workinger, J.L., Doyle, R.P., and Bortz, J. (2018). Challenges in the diagnosis of magnesium status. Nutrients, 10.","DOI":"10.3390\/nu10091202"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dneu.22579","article-title":"Folate action in nervous system development and disease","volume":"78","author":"Balashova","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hsu, H.C., Chiou, J.F., Wang, Y.H., Chen, C.H., Mau, S.Y., Ho, C.T., Chang, P.J., Liu, T.Z., and Chen, C.H. (2013). Folate deficiency triggers an oxidative-nitrosative stress-mediated apoptotic cell death and impedes insulin biosynthesis in RINm5F pancreatic islet \u03b2-cells: Relevant to the pathogenesis of diabetes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077931"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bajic, Z., Sobot, T., Skrbic, R., Stojiljkovic, M.P., Ponorac, N., Matavulj, A., and Djuric, D.M. (2022). Homocysteine, vitamins B6 and folic acid in experimental models of myocardial infarction and heart failure how strong is that link?. Biomolecules, 12.","DOI":"10.3390\/biom12040536"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1756287216675778","article-title":"The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction","volume":"9","author":"Andersson","year":"2017","journal-title":"Ther. Adv. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Miyata, Y., Matsuo, T., Mitsunari, K., Asai, A., Ohba, K., and Sakai, H. (2019). A review of oxidative stress and urinary dysfunction caused by bladder outlet obstruction and treatments using antioxidants. Antioxidants, 8.","DOI":"10.3390\/antiox8050132"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5213\/inj.2448002.001","article-title":"Pathophysiology of overactive bladder and pharmacologic treatments including \u03b23-adrenoceptor agonists\u2014Basic research perspectives","volume":"28","author":"Kwon","year":"2024","journal-title":"Int. Neurourol. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/odi.12446","article-title":"Vitamin C: The known and the unknown and Goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1442-2042.2006.01217.x","article-title":"Nocturnal enuresis and overactive bladder in children: An epidemiological study","volume":"13","author":"Kajiwara","year":"2006","journal-title":"Int. J. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/nau.24113","article-title":"Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort","volume":"38","author":"Cameron","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_39","first-page":"341","article-title":"Sonographic measurement of bladder wall thickness in healthy children","volume":"19","author":"Sorkhi","year":"2009","journal-title":"Iran. J. Pediatr."},{"key":"ref_40","first-page":"S32","article-title":"Evaluation of voiding dysfunction and measurement of bladder volume","volume":"6","author":"Kelly","year":"2004","journal-title":"Rev. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The Validation of the Patient Perception of Bladder Condition (PPBC): A Single-Item Global Measure for Patients with Overactive Bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nure.12090","article-title":"Guidelines for Optimizing Design and Analysis of Clinical Studies of Nutrient Effects","volume":"72","author":"Heaney","year":"2014","journal-title":"Nutr. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09513590.2012.743020","article-title":"Endocrine and Clinical Effects of Myo-Inositol Administration in Polycystic Ovary Syndrome: A Randomized Study","volume":"29","author":"Artini","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Akaihata, H., Matsuoka, K., Hata, J., Harigane, Y., Yaginuma, K., Endo, Y., Imai, H., Matsuoka, Y., Onagi, A., and Tanji, R. (2023). Involvement of mast-cell-tryptase- and protease-activated receptor 2\u2013mediated signaling and urothelial barrier dysfunction with reduced uroplakin II expression in bladder hyperactivity induced by chronic bladder ischemia in the rat. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043982"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/5\/604\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:28:24Z","timestamp":1777462104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/5\/604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["children13050604"],"URL":"https:\/\/doi.org\/10.3390\/children13050604","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}